Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1)

Fig. 5

Sevoflurane inhibits the Akt/mTOR signaling pathway and MMP-9 activity. a SKOV3 and OVCAR3 cells were treated with sevoflurane for 48 h, the effects of sevoflurane on Akt/mTOR signaling pathway were analyzed by western blot assay. b Gelatin zymography assay was used to examine the effect of sevoflurane on MMP-9 activity. The data were expressed as the mean ± SD from three independent experiments. *P < 0.05 vs. the negative control group

Back to article page
\